COMMUNIQUÉS West-GlobeNewswire

BeyondSpring to Host Second-Quarter 2019 Financial Results and Operational Update Conference Call on September 18, 2019
11/09/2019
NEW YORK, Sept. 11, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today [...]
Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
11/09/2019
NEW YORK, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today [...]
Dr Kristi Kuper Joins DoseMe as Director of Clinical Pharmacy
11/09/2019
MOORESTOWN, N.J., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced pharmacy executive Dr [...]
Emerald Health Therapeutics conclut un partenariat avec HelloMD afin de poursuivre l'expansion de son programme de cannabis médical destiné aux patients
11/09/2019
La nouvelle plate-forme intégrée de notre partenaire permet de rationaliser l'accès des patients aux avis médicaux, d'améliorer l'expérience des patients d'Emerald et de stimuler l'expansion des services médicaux [...]
Momotaro-Gene Announces First Patient Dosed in Phase 2 Clinical Trial of MTG201 in Combination with Nivolumab in Patients with Relapsed Malignant Pleural Mesothelioma
11/09/2019
Combination of Novel Gene Therapy and Immunotherapy Being Evaluated for Synergistic Anti-Tumor Activity in Patients with Cancer with Limited Treatment Options OKAYAMA, Japan, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Momotaro- [...]
vTv Therapeutics to Present Posters at Two Scientific Conferences in September
11/09/2019
Presenting New Clinical Data from Phase 2 Study in Type 1 Diabetes with Liver Selective GKA Program Pre-Clinical Data in NASH with the NRF2/Bach1 Program HIGH POINT, N.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- vTv [...]
Kintai Therapeutics Appoints Senior Executive Dr. Mark E. Nuttall as Chief Business Officer
11/09/2019
CAMBRIDGE, Mass. , Sept. 11, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a biotech company pioneering precision medicines by unlocking the power of the enteric signaling network, today announced the appointment of [...]
Emerald Health Therapeutics Forms Partnership With HelloMD to Continue Expanding its Medical Cannabis Patient Program
11/09/2019
New partner-integrated platform to further streamline patient access to medical advice, enhancing Emerald’s patient experience and driving medical expansion VANCOUVER, British Columbia, Sept. 11, 2019 (GLOBE NEWSWIRE [...]
Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical
11/09/2019
BUFFALO, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Exactus, Inc. Announces Participation in the Investor Summit and the Sidoti & Company Fall 2019 Conference
11/09/2019
DELRAY BEACH, Fla., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that management will present at the [...]
Capital Senior Living Corporation Grants Executive Vice President and Chief Operating Officer Brandon M. Ribar Inducement Awards Pursuant to NYSE Rule 303A.08
11/09/2019
DALLAS, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU), one of the nation’s largest operators of senior housing communities, today announced that on September 10, 2019 ( [...]
New Data Presented at ECTRIMS Reinforce Long-term Benefits of TECFIDERA® (dimethyl fumarate) Over 10 Years
11/09/2019
TECFIDERA consistently maintained low levels of disease activity with no increased risk in adverse events over a decade of treatment Latest interim data from Phase 3 EVOLVE-MS-1 trial show Biogen and Alkermes’ [...]
Trading in Coloplast shares by board members, executives or associated persons
11/09/2019
Please see enclosed pdf. Attachment 11092019_trading in shares_NP
Trading in Coloplast shares by board members, executives or associated persons
11/09/2019
Please see enclosed pdf. Attachment 11092019_trading in shares_GL
Major shareholder announcement
11/09/2019
Company announcement 11 September 2019 Major shareholder announcement Pursuant to section 30 of Consolidated Act no. 459 of 24 April 2019 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces [...]
Zealand Pharma completes subscription of new shares and registration of capital increase
11/09/2019
Company announcement – No. 33 / 2019 Zealand Pharma completes subscription of new shares and registration of capital increase Copenhagen, September 11, 2019 – With reference to the company announcement no. 30/2019 dated [...]
Trading in GN Store Nord shares by board members, executives and associated persons
11/09/2019
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
Emerald Health Therapeutics annonce un financement de parts de débentures convertibles de 25 millions USD
11/09/2019
CE COMMUNIQUÉ DE PRESSE NE DOIT PAS ÊTRE DISTRIBUÉ AUX AGENCES DE PRESSE AMÉRICAINES ET NE DOIT PAS ÊTRE DIFFUSÉ AUX ÉTATS-UNIS VANCOUVER, Colombie-Britannique, 10 sept. 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]
Digirad Corporation Acquires ATRM Holdings, Inc.
10/09/2019
Transforms into a Diversified Holding Company Completes Private Placement of Preferred Stock for $3.0 Million SUWANEE, Ga., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or the “ [...]

Pages